MISSIONPHARMA A/S — Credit Rating and Financial Key Figures
CVR number: 26902398
Vassingerødvej 9, 3540 Lynge
info@missionpharma.com
tel: 48163248
Income statement (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 731.47 | 693.96 | 924.32 | 928.80 | 729.80 |
| Costs of manufacturing | - 398.28 | - 571.60 | - 545.38 | - 468.04 | |
| External services | - 173.42 | - 123.38 | - 163.46 | -99.33 | |
| Gross profit | 171.93 | 122.25 | 229.34 | 119.75 | 73.30 |
| Employee benefit expenses | -48.34 | -65.44 | -65.69 | -66.65 | |
| Other operating expenses | -0.70 | ||||
| Total depreciation | -1.59 | -4.30 | -2.93 | -3.29 | |
| EBIT | 171.93 | 71.63 | 159.60 | 151.34 | 92.48 |
| Other financial income | 0.21 | 3.93 | 6.00 | 4.96 | |
| Other financial expenses | -0.84 | -9.13 | -3.46 | -2.94 | |
| Net income from associates (fin.) | 2.67 | ||||
| Pre-tax profit | 83.61 | 73.67 | 154.40 | 153.88 | 94.50 |
| Income taxes | -15.69 | -35.14 | -34.13 | -21.20 | |
| Net earnings | 83.61 | 57.98 | 119.26 | 119.75 | 73.30 |
Assets (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 1.29 | 12.56 | |||
| Intangible assets total | 1.29 | 12.56 | |||
| Land and waters | 22.51 | 24.90 | 23.88 | 25.74 | |
| Buildings | 1.19 | 4.82 | 6.13 | 6.37 | |
| Tangible assets total | 23.71 | 29.72 | 30.01 | 32.11 | |
| Participating interests | 33.20 | ||||
| Other non-current investments | 18.42 | 18.29 | 17.84 | ||
| Investments total | 427.21 | 33.20 | 18.42 | 18.29 | 17.84 |
| Non-current loans receivable | 0.44 | 2.19 | 0.39 | ||
| Long term receivables total | 0.44 | 2.19 | 0.39 | ||
| Finished products/goods | 32.46 | 111.48 | 125.30 | 124.68 | |
| Inventories total | 32.46 | 111.48 | 125.30 | 124.68 | |
| Current trade debtors | 35.72 | 62.23 | 57.66 | 60.18 | |
| Current amounts owed by group member comp. | 262.50 | 212.39 | 153.46 | 87.04 | |
| Prepayments and accrued income | 20.61 | 73.61 | 22.20 | 26.67 | |
| Current other receivables | 9.04 | 4.56 | 6.07 | 2.68 | |
| Current deferred tax assets | 2.19 | 12.26 | 20.05 | 17.32 | |
| Short term receivables total | 330.05 | 365.05 | 259.45 | 193.89 | |
| Cash and bank deposits | 9.10 | 25.04 | 33.77 | 27.52 | |
| Cash and cash equivalents | 9.10 | 25.04 | 33.77 | 27.52 | |
| Balance sheet total (assets) | 427.21 | 428.52 | 550.15 | 470.29 | 408.99 |
Equity and liabilities (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 332.43 | 2.00 | 2.10 | 2.10 | 2.10 |
| Shares repurchased | 90.00 | 150.00 | 119.00 | 73.00 | |
| Other reserves | 35.69 | -2.34 | -2.61 | -3.19 | |
| Retained earnings | -83.61 | 127.14 | 80.70 | 81.08 | 127.92 |
| Profit of the financial year | 83.61 | 57.98 | 119.26 | 119.75 | 73.30 |
| Minority interest (BS) | 1.35 | 1.20 | 1.07 | ||
| Shareholders equity total | 332.43 | 312.81 | 351.07 | 320.52 | 274.21 |
| Provisions | 7.21 | 9.65 | 12.07 | ||
| Non-current other liabilities | 7.21 | 9.65 | 12.07 | ||
| Non-current deferred tax liabilities | 1.79 | ||||
| Non-current liabilities total | 1.79 | 7.21 | 9.65 | 12.07 | |
| Advances received | 33.92 | 104.28 | 76.37 | 48.43 | |
| Current trade creditors | 53.42 | 56.61 | 25.20 | 44.37 | |
| Current owed to group member | 0.86 | 4.69 | 0.45 | ||
| Other non-interest bearing current liabilities | 25.72 | 30.97 | 33.86 | 29.46 | |
| Current liabilities total | 113.92 | 191.87 | 140.12 | 122.71 | |
| Balance sheet total (liabilities) | 332.43 | 428.52 | 557.37 | 479.95 | 421.06 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.